ANN ARBOR, Mich.--(BUSINESS WIRE)--Forever Labs, the first company to bank young adult stem cells, so you can live a healthier and longer life, today announced that it has closed $2 million in financing from Northwestern Mutual, Silicon Badia Ventures, Babel Ventures, Aaron Hirschhorn, founder and CEO of DogVacay, and notable members of the medical community including Dr. Michael Dobryansky, Dr. Timothy Davis, Dr. Michael Schenden, among others. Forever Labs will dedicate resources to continue pioneering stem cell research breakthroughs and accelerate brand development.
Founded in 2015, Forever Labs is a longevity company transforming the healthcare industry by preserving healthy stem cells for future therapies that combat age-related diseases, as well as aging itself. The proprietary procedure involves a certified Forever Labs physician collecting one’s mesenchymal stem cells (MSCs), which have the ability to stimulate tissues to grow and repair themselves when you need it most. After a simple, 15-minute outpatient procedure, the stem cells are cryogenically frozen and safely stored agnostically in an FDA-compliant clinical-grade biorepository until needed.
Forever Labs is the culmination of decades of experience by board-certified biomedical research scientists and medical doctors. As the global stem cell market is expected to reach $15.63 billion by 2025, founders Steven Clausnitzer and Mark Katakowski, PhD are leading the company’s latest studies to show the positive impact stem cells can have on extending lifespan.
“After years of research, studies continue to show that older animals treated with younger stem cells were living significantly healthier and longer lives. Mark and I knew it was only a matter of time before this could be applied to humans and become a major breakthrough for treating age-related diseases,” said Steven Clausnitzer, co-founder and CEO. “We created Forever Labs as a solution to store those younger cells now, so people will live healthier and longer lives. We’re thrilled to have the support of such a well-respected group of investors that are helping us bring this vision to scale.”
"As someone that has been developing therapies using these cells for more than 15 years, I expect that stem cell banking will become a cornerstone of good medicine. There is simply too much value in them that is lost to time,” said Mark Katakowski, PhD, co-founder and President.
“The Forever Labs team is on the forefront of stem cell research and pushing the science for longevity forward, I myself have personally experienced the breakthroughs of this science with knee and back injuries,” said Aaron Hirschhorn, founder and CEO of DogVacay. “The discovery and dedication to finding innovative ways to help health maintenance as opposed to disease treatment has life-changing implications, and I look forward to working closely with the team as this technology is propelled forward by increased adoption.”
As one ages, the decline in MSCs leads to age-related diseases such as stroke, heart disease, and osteoporosis, which in turn results in a drastic increase of medical costs. According to studies from Health Services Research, almost 80% of lifetime healthcare expenditures occur after age 40. Forever Labs was created to preserve healthy stem cells to later rejuvenate one’s MSC population to significantly delay the onset of those age-related diseases and extend a healthy lifespan.
About Forever Labs
Forever Labs is the first company to bank young adult stem cells, so you can live a healthier and longer life. Research on stem cells suggest that as you age, you lose stem cells and the ones that remain become damaged and less effective. As a longevity company and an educational force in stem cell research, Forever Labs is transforming the healthcare industry by preserving your stem cells for future therapies that combat age-related diseases, as well as aging itself. Forever Labs provides you with access to invest in the benefits of your stem cells now for future health maintenance and disease management. Forever Labs was founded in 2015 by Mark Katakowski and Steven Clausnitzer. For more information, please visit www.foreverlabs.com.